Table 2 Univariate analysis of predictive factors of EV in 146 patients

Age (yr)

54.8 ± 13.6

52.5 ± 11.7

0.327

Male (%)

75.7

65.1

0.236

Child-Pugh score

8(6–9)

8(7–9)

0.789

Child-Pugh class

0.487

   A

12(33%)

25(23%)

   B

16(43%)

57(52%)

   C

9(24%)

27(25%)

Total Bilirubin (μmol/L)

41.4 ± 40.7

46.9 ± 60.0

0.607

Conjugated bilirubin(μmol/L)

18.2 ± 21.0

20.6 ± 34.9

0.988

Total protein (g/L)

64.1 ± 5.3

63.2 ± 7.2

0.467

Albumin (g/L)

31.3 ± 6.2

31.9 ± 6.3

0.596

ALT (U/L)

75.6 ± 95.8

57.0 ± 51.8

0.139

AST (U/L)

91.5 ± 99.1

76.7 ± 58.3

0.273

ALT/AST ratio

0.79 ± 0. 33

0. 77 ± 0. 27

0.719

Alkaline phosphatase (U/L)

109.4 ± 41.0

108.9 ± 70.9

0.969

γ- GT (U/L)

115.6 ± 139.1

82.3 ± 94.6

0.106

Prothrombin time(s)

18.7 ± 5.5

18.3 ± 4.1

0.691

Prothrombin activity (%)

60.4 ± 17.9

60.7 ± 15.2

0.925

Platelets (10⁹/L)

79.6 ± 51.1

55.3 ± 30.1

< 0.001

Ascites (%)

48.6

64.2

0.094

Platelets/Spleen width

1.89 ± 1.39

1.15 ± 0.82

< 0.001

Spleen width (mm)

44.8 ± 7.6

52.5 ± 10.1

< 0.001

Portal vein diameter (mm)

11.6 ± 1.3

12.9 ± 1.9

< 0.001